Wale(s) of experience

Arthurian plans 10-12 drug, Dx, medtech investments for Welsh fund

Wale(s) of experience

A group of seasoned life science investors, academics and former executives surfaced last week as board members of Sir Chris Evans' new investment firm Arthurian Life Sciences. The group's first task is managing

Read the full 357 word article

How to gain access

Continue reading with a
two-week free trial.